Renovaro Inc (RENB)
0.97
+0.05
(+5.75%)
USD |
NASDAQ |
May 17, 16:00
0.97
0.00 (0.00%)
After-Hours: 20:00
Renovaro Max Drawdown (5Y): 96.81% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.81% |
March 31, 2024 | 96.81% |
February 29, 2024 | 96.81% |
January 31, 2024 | 96.81% |
December 31, 2023 | 96.81% |
November 30, 2023 | 96.81% |
October 31, 2023 | 96.81% |
September 30, 2023 | 96.81% |
August 31, 2023 | 96.81% |
July 31, 2023 | 96.81% |
June 30, 2023 | 96.81% |
May 31, 2023 | 92.84% |
April 30, 2023 | 92.75% |
March 31, 2023 | 92.75% |
February 28, 2023 | 92.75% |
January 31, 2023 | 91.79% |
December 31, 2022 | 91.79% |
November 30, 2022 | 88.01% |
October 31, 2022 | 86.89% |
September 30, 2022 | 86.45% |
August 31, 2022 | 86.45% |
July 31, 2022 | 86.45% |
June 30, 2022 | 84.62% |
May 31, 2022 | 77.51% |
April 30, 2022 | 77.51% |
Date | Value |
---|---|
March 31, 2022 | 77.51% |
February 28, 2022 | 77.51% |
January 31, 2022 | 77.51% |
December 31, 2021 | 77.51% |
November 30, 2021 | 77.51% |
October 31, 2021 | 77.51% |
September 30, 2021 | 77.51% |
August 31, 2021 | 77.51% |
July 31, 2021 | 77.51% |
June 30, 2021 | 77.51% |
May 31, 2021 | 77.51% |
April 30, 2021 | 77.51% |
March 31, 2021 | 77.51% |
February 28, 2021 | 77.51% |
January 31, 2021 | 77.51% |
December 31, 2020 | 77.51% |
November 30, 2020 | 77.51% |
October 31, 2020 | 77.51% |
September 30, 2020 | 77.51% |
August 31, 2020 | 77.51% |
July 31, 2020 | 77.51% |
June 30, 2020 | 77.51% |
May 31, 2020 | 77.51% |
April 30, 2020 | 77.51% |
March 31, 2020 | 77.51% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
51.53%
Minimum
May 2019
96.81%
Maximum
Jun 2023
80.26%
Average
77.51%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
DIH Holding US Inc | -- |
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -30.75 |
Beta (5Y) | 0.4395 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 167.0% |
Historical Sharpe Ratio (5Y) | -0.1548 |
Historical Sortino (5Y) | -0.5079 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.62% |